476 filings
ARS
2023 FY
RGEN
Repligen Corp.
1 Apr 24
Annual report to shareholders
4:32pm
DEFA14A
RGEN
Repligen Corp.
1 Apr 24
Additional proxy soliciting materials
4:21pm
DEF 14A
RGEN
Repligen Corp.
Definitive proxy
1 Apr 24
4:17pm
8-K
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
10-K
2023 FY
RGEN
Repligen Corp.
Annual report
22 Feb 24
4:26pm
8-K
v58v5fz1sdqq
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
8-K
s99xaro
15 Dec 23
Entry into a Material Definitive Agreement
4:33pm
8-K
7opyjts85 yajo
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
8-K
u1b85wukf3j9j jp
31 Oct 23
Repligen Reports Third Quarter 2023 Financial Results
7:48am
8-K
ganmdl
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
8-K
a2l 0xnd9o5pu75bivtv
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
fkmot wjmhk5t9
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
nahsd
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
qe3vyyw46h1ghk6wlkn
22 May 23
Amendments to Articles of Incorporation or Bylaws
9:28am
8-K
hszvy9b1sqy5yxjtxy
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am
8-K
footnab9
18 Apr 23
Other Events
7:26am
8-K
hm4czx ald6bbgq0vm
12 Apr 23
Regulation FD Disclosure
7:31am